ArticleAnnals of medicine2022
Rewarding recovery: the time is now for contingency management for opioid use disorder.
Article in Annals of medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 30 citations in OpenAlex.
- A Behavioral Economic Characterization of the Impact of the COVID-19 Quarantine on Reinforcer Diversity, Behavior, and Health.Perspectives on behavior science · 2026Review
- Contingency Management for Stimulant-Opioid Co-Use: A Systematic Review and Meta-Analysis.Journal of addiction medicine · 2026Article
- Patient preferences for incentives in Contingency Management interventions in methadone treatment: A best-worst scale analysis.PloS one · 2026Article
- Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): preparation phase outcomes of a hybrid type 3 trial.Implementation science communications · 2025Article
- Why All Behavioral Health Providers Need Addiction Training.The journal of behavioral health services & research · 2025Article
- Digital Contingency Management for Substance Use Disorder Treatment: 12-Month Quasi-Experimental Design.JMIR mental health · 2025Article
- Pilot testing a novel remotely delivered intensive outpatient program for hospitalized patients with opioid use disorder.Addiction science & clinical practice · 2025Article
- Addiction specialists' perspectives on digital contingency management and its role within UK drug and alcohol services: A qualitative exploration.Drug and alcohol review · 2025Article
- Using the IFASIS (Inventory of Factors Affecting Successful Implementation and Sustainment) to advance context-specific and generalizable knowledge of implementation determinants: case study of a digital contingency management platform.Implementation science communications · 2025Article
- Substance use and psychiatric outcomes following substance use disorder treatment: An 18-month prospective cohort study in Chile.Addiction (Abingdon, England) · 2025Article
- Risk of Relapse Following Discharge from Non-Hospital Residential Opioid Use Disorder Treatment: A Systematic Review of Studies Published from 2018 to 2022.Substance abuse and rehabilitation · 2025Review
- Evolution of the substance use landscape: Implications for contingency management.Journal of applied behavior analysis · 2025Review
- Self-Reported Advantages and Disadvantages of Online Networking About Opioid Misuse Among Those Who Have or Are Currently Misusing Opioids.Substance use & misuse · 2025Article
- Digitally delivered contingency management during methadone treatment for people with co-occurring cocaine and opioid use: a protocol for a randomized controlled trial.Frontiers in psychiatry · 2025Article
- Smartphone App-Based Contingency Management and Opioid Use Disorder Treatment Outcomes.JAMA network open · 2024Article
- Article
- Longitudinal trajectories of substance use disorder treatment use: A latent class growth analysis using a national cohort in Chile.Addiction (Abingdon, England) · 2024Article
- Lessons learned from statewide contingency management rollouts addressing stimulant use in the Northwestern United States.Preventive medicine · 2023Article
- Impulsivity in amphetamine use disorder: Examination of sex differences.Addiction (Abingdon, England) · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
Contingency management (i.e. rewarding people, often with money, for achieving their recovery goals) is backed by decades of empirical support yet remains highly underutilized. Rewards are rarely used in real-world clinical practice due to a number of concerns, including most notably, the apparent lack of innovation, as well as moral, philosophical, ethical, and economic concerns, and even federal rules meant to prevent illegal inducements in health care. Still, other opponents argue that some patients will try to "game" the system by simply doing whatever it takes to earn monetary rewards. This paper provides a succinct, up-to-date overview of the current evidence base for contingency management for opioid use disorder. Common barriers and solutions to implementation, as well as implications for future research and clinical practice are discussed. Although important, greater uptake of contingency management interventions is about more than legislation and regulations; it's about recognizing stigma, shaping attitudes, and increasing awareness. Provider involvement in advocacy efforts at all levels and collaboration involving academic-industry partnerships is necessary to advance the burgeoning digital health care space and improve outcomes for people with opioid use disorder. Key MessagesContingency management is highly effective but highly underutilized.Low uptake is largely attributed to a lack of innovation and moral, ethical, and economic concerns, among other barriers.Technology-enabled solutions and academic-industry partnerships are critical to advance opioid use disorder care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.